Puerto Rico Doctor Permanently Loses DEA Controlled Substances License
Published Date: 9/21/2026
Notice
Summary
Dr. Esther Villanueva Valdes from Puerto Rico lost her DEA registration because she’s no longer allowed to handle controlled substances and was excluded from federal health programs like Medicare and Medicaid. She didn’t ask for a hearing, so the decision to revoke her registration is final. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
DEA Registration Revoked in Puerto Rico
DEA Certificate of Registration No. BV4657485 issued to Dr. Esther Villanueva Valdes is revoked, effective October 21, 2026. As of that date, she may not lawfully prescribe, dispense, or otherwise handle controlled substances, and any pending applications to renew, modify, or obtain DEA registration in Puerto Rico are denied.
Mandatory Exclusion From Federal Health Programs
Dr. Villanueva Valdes was mandatorily excluded from participation in Medicare, Medicaid, and all Federal health care programs effective March 20, 2022 for a minimum period of 8 years under 42 U.S.C. 1320a-7(a). This exclusion is an independent basis for denying or revoking DEA registration.
State Medical and Controlled-Substance Licenses Lapsed
The record shows Dr. Villanueva Valdes's Puerto Rico medical license expired on July 4, 2022 and her Puerto Rico controlled substance license expired on August 31, 2023; DEA found she is not licensed to practice medicine in Puerto Rico. Those lapsed state licenses support revocation of her DEA registration.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-19231, Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Starting October 21, 2026, diphenidine and its related forms will be officially listed as Schedule I drugs, meaning they’re considered highly controlled with no accepted medical use. This change affects anyone who makes, sells, studies, or even possesses diphenidine, bringing strict rules and serious penalties. The move helps the U.S. follow international drug laws and keep communities safer.
2026-18604, Joseph John Stubbers III, D.O.; Decision and Order
Dr. Joseph John Stubbers III from Ohio lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in Ohio. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of February 28, 2026. This means he can’t legally prescribe or manage controlled drugs anymore, impacting his medical practice and patients.
2026-18597, Craig Cohen, DPM; Decision and Order
Dr. Craig Cohen from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t respond to the DEA’s attempts to contact him or request a hearing, so the agency revoked his certificate. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
2026-18605, Emran Mohammad, RN, APRN, CNP; Decision and Order
Emran Mohammad, a nurse practitioner from Minneapolis, lost his DEA registration because he no longer has state permission to handle controlled substances. The DEA tried hard to contact him but couldn’t reach him, so they decided it’s best for public safety to revoke his registration. This means he can’t legally prescribe or handle controlled drugs anymore, effective immediately.
Previous / Next Documents
Previous: 2026-19230, John Ramsay Walters, M.D.; Decision and Order
Dr. John Ramsay Walters from California lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of May 31, 2026. This means he can’t legally prescribe or dispense controlled drugs anymore, affecting his medical practice and patients.
Next: 2026-19233, Notice of Supplemental Funding, State Offices of Rural Health Coordination and Development Program
HRSA is giving an extra $345,000 to the National Organization of State Offices of Rural Health to help rural health programs grow stronger and work better together. This money, available from August 2026 to July 2027, will boost training, planning, and support for rural health groups across the country. It’s all about making sure rural communities get the health care help they need, faster and smarter.